QXO Inc. Registers Convertible Preferred Stock and Common Share Resale Rights Following January 2026 Investment Agreement

Investment Agreement Foundation and Registration Obligations

QXO, Inc. entered into an Investment Agreement dated January 5, 2026, with multiple investor parties, creating obligations to register specific securities for resale. The company has now satisfied those registration requirements by filing a prospectus supplement on July 23, 2026. This supplement operates under the umbrella of the company's broader Form S-3ASR registration statement, originally filed with the Securities and Exchange Commission on July 29, 2024. The relationship between these documents allows the company to efficiently register secondary offerings by named selling stockholders without requiring a separate, standalone registration statement.

Registration rights for convertible securities are standard protective mechanisms in institutional investment agreements. By filing the prospectus supplement, QXO provides a legal pathway for investors to liquidate or trade their holdings in the open market, subject to applicable securities laws and resale conditions. The January 2026 investment clearly involved both debt-like instruments—the Series C Convertible Perpetual Preferred Stock—and a substantial number of underlying common equity shares that may be obtained upon conversion. The prospectus supplement formalizes the availability of these securities for public resale by the named selling stockholders identified in the document.

Scale of Convertible Securities and Preferred Share Holdings

The prospectus supplement covers a material volume of convertible securities. Specifically, the registration encompasses 41,405,099 shares of QXO's common stock that are issuable upon the conversion of Series C Convertible Perpetual Preferred Stock. Additionally, the supplement registers 96,267 shares of the Preferred Stock itself for resale. While the prospectus supplement does not disclose the specific conversion ratio, dilution timing, or conditions under which conversion may be triggered, these figures indicate that the January 2026 investment round involved a significant equity commitment. The common share equivalents represent a meaningful proportion of potential future share count expansion if and when conversion events occur.

The distinction between registering the Preferred Stock shares and the underlying common shares reflects the dual-track nature of convertible securities regulation. Investors holding Preferred Stock may wish to sell those instruments directly to other preferred investors, or they may convert to common equity and sell on public markets. By registering both forms, QXO accommodates multiple liquidity pathways. The company did not disclose in this filing the purchase price per preferred share, the conversion price, the dividend or distribution rate applicable to the Preferred Stock, or the circumstances triggering mandatory conversion, if any. Investors seeking those details would need to consult the full Investment Agreement or prospectus supplement itself, which are available through the Securities and Exchange Commission's EDGAR database.

Registration Statement Structure and Legal Framework

QXO's approach to registering these securities leverages its existing Form S-3ASR registration statement, a shelf registration that provides ongoing registration authority for multiple future offerings. The original S-3ASR was filed on July 29, 2024, under File No. 333-281084. Shelf registrations allow issuers to register securities in advance, then issue or permit resale of those securities over time without filing new registration statements each time, provided such sales occur within the stated shelf period. By incorporating the prospectus supplement into the S-3ASR framework, QXO streamlines the administrative process while ensuring that the resale rights required by the Investment Agreement are properly formalized and legally compliant.

The use of a prospectus supplement rather than a standalone prospectus is significant from a disclosure and efficiency standpoint. A supplement updates and modifies the base prospectus without replacing it entirely, incorporating existing disclosure by reference. This approach reduces redundancy and keeps the regulatory record organized. The company engaged Paul, Weiss, Rifkind, Wharton & Garrison LLP to provide a legal opinion regarding the validity and proper registration of the shares, a customary requirement for shelf takedowns. That opinion is filed as Exhibit 5.1 to the current report and is expressly incorporated into the S-3ASR registration statement, adding a layer of legal assurance for potential purchasers or resellers.

Series C Convertible Perpetual Preferred Stock Characteristics

The Series C Convertible Perpetual Preferred Stock represents a specialized financing instrument that sits between traditional debt and equity. The term "perpetual" indicates that the Preferred Stock has no maturity date, distinguishing it from bonds or other time-limited securities. "Convertible" means holders may exchange their Preferred Stock for common equity at predetermined terms. "Mandatory convertible" language in some convertible preferred arrangements indicates automatic conversion under specified conditions, though the present filing does not detail whether QXO's Series C includes mandatory conversion triggers or relies on investor election.

Perpetual convertible preferred securities are often used in growth-stage or strategically significant investments because they provide investors with downside protection (preferred liquidation rights or fixed dividend streams) while retaining upside participation through conversion to common stock. The fact that QXO issued Series C Perpetual Preferred Stock—and earlier series designations suggest this is not the company's first preferred issuance—indicates the company may be utilizing a tiered capital structure to accommodate different investor profiles and risk tolerances. The prospectus supplement does not disclose dividend rates, liquidation preferences, voting rights, or conversion mechanics specific to Series C; those terms are presumably detailed in the prospectus supplement itself or the underlying Investment Agreement.

Regulatory and Compliance Context for Resale Registration

Resale registration under Rule 415 of the Securities Act of 1933 is a standard mechanism by which companies honor contractual commitments to permit institutional investors to liquidate holdings. When an investment agreement includes registration rights, the issuer agrees to register the investor's securities for public resale, removing one barrier to investor exit or portfolio rebalancing. QXO's filing of the prospectus supplement demonstrates compliance with its contractual obligations and provides named selling stockholders with SEC-approved documentation for effecting sales in the open market or through broker-assisted transactions.

The timing of the prospectus supplement filing—nearly six months after the Investment Agreement date—is not unusual, as issuers typically prepare registration statements after initial investment closes and the investor's securities are fully issued and capitalized. The disclosure notes that the prospectus supplement is filed "in satisfaction of" registration obligations, language confirming that this action directly addresses terms of the January 2026 agreement. The company also confirms non-emerging growth status, meaning it is not entitled to scaled disclosure accommodations available to smaller public companies and must comply with full-scale disclosure and auditing standards.

Legal Opinions and Documentation Support

Paul, Weiss, Rifkind, Wharton & Garrison LLP, a leading international law firm, provided a legal opinion letter affirming that the registered shares are validly issued, fully paid, and nonassessable, and that the registration statement appropriately covers the securities for public resale. This opinion, filed as Exhibit 5.1, is a material component of the registration package. Underwriters, investors, and trading partners typically require such opinions to confirm that the securities are legally authorized and registered without defect. The fact that a major institutional law firm has rendered this opinion adds credibility to the registration and may facilitate trading activity among market participants.

The consent of Paul, Weiss (Exhibit 23.1) confirms that the firm has authorized use of its opinion in connection with the registration statement and prospectus supplement. This consent is a regulatory requirement ensuring that the law firm stands behind its work and acknowledges its participation in the public filing. Such formalities, while procedural, reflect the layers of oversight and due diligence that accompany public securities offerings, even when those offerings consist of resales by existing investors rather than new issuances by the company itself.

Impact on Outstanding Shares and Capital Structure

The registration of 41.4 million common shares convertible from Series C Preferred Stock has implications for QXO's potential future share count. If and when conversion occurs, these shares would be added to the company's common equity base, increasing the total shares outstanding and potentially diluting existing common shareholders' ownership percentage. However, conversion is not automatic under this filing—the prospectus supplement merely makes these securities available for resale by the named stockholders and does not trigger conversion events itself. Investors holding common stock should monitor conversion terms, mandatory conversion triggers, and any pricing or timing conditions disclosed in supplementary documents.

The company did not disclose the number of shares currently outstanding, the fully diluted share count including all convertible securities, or pro-forma ownership percentages that would result from conversion of the Series C Preferred Stock. These metrics would typically appear in QXO's most recent quarterly or annual report to the Securities and Exchange Commission. The prospectus supplement is focused narrowly on resale registration and therefore does not provide a comprehensive capital structure overview. Investors evaluating dilution impact should cross-reference this filing with the company's latest 10-Q or 10-K report for fuller context on existing share counts and cumulative dilution from all issuances.

Investor Liquidity Pathways and Market Considerations

By registering these securities, QXO has facilitated potential liquidity events for the named selling stockholders involved in the January 2026 investment round. These investors may now offer their common shares or Preferred Stock for sale in the public markets, subject to customary trading restrictions such as Rule 144 holding periods and volume limitations for affiliate resellers. The prospectus supplement itself does not impose timing constraints on when resales must or may occur; that is a matter of investor discretion and market conditions. Over time, as these shares are offered and sold, the float of QXO common stock may expand, potentially affecting trading volumes and liquidity metrics.

The prospectus supplement does not forecast or estimate how many shares will actually be resold or over what timeframe such sales might occur. Institutional investors frequently hold convertible or preferred securities for extended periods, selling only when liquidity needs arise, pricing conditions are favorable, or investment theses mature. The act of registering the securities removes the legal impediment to resale but does not guarantee or encourage any particular pace of liquidation. Market observers and existing QXO shareholders should remain aware that large resales could influence share price movement, and the prospect of future conversion and resale may be factored into current equity valuations.

Corporate Governance and Filing Transparency

The prospectus supplement was signed by Christopher Signorello, identified as Chief Legal Officer of QXO, Inc., on July 23, 2026, the same date as the filing. This timing indicates that the company's legal and compliance teams worked to finalize and execute the prospectus supplement in coordination with the Securities and Exchange Commission's electronic filing systems. The inclusion of a legal officer's signature underscores accountability for the accuracy and completeness of disclosures made in connection with the registration. The 8-K report format used to announce the prospectus supplement is appropriate for material events such as registration of significant securities holdings, and the filing structure follows the required framework outlined in Securities and Exchange Commission regulations.

QXO's principal executive offices are located in Greenwich, Connecticut, and the company trades on the New York Stock Exchange under the ticker QXO for common stock. The company's internal Revenue Service Employer Identification Number is 16-1633636, and its commission file number with the Securities and Exchange Commission is 001-38063, enabling investors to locate related filings and disclosures through public databases. The filing confirms that the company is a Delaware corporation, standard for publicly listed entities, and maintains robust administrative infrastructure to manage securities issuances and registrations.